|Title||Choosing Wisely: The Canadian Rheumatology Association Pediatric Committee's List of Items Physicians and Patients Should Question|
|Publication Type||Journal Article|
|Year of Publication||2023|
|Authors||Lim L, McMillan T, Chedeville G, Lahiry P, Lee JYL, Heale LD, Human AL, McGrath TR, MacQueen SE, Stringer E, Jariwala MP, Neufeld KM, Soon GS, Spiegel LR, Luca NJC|
We have identified areas for quality improvement in the evaluation and treatment of rheumatic diseases in Canadian children. The highest composite score items were antinuclear antibody testing, drug toxicity monitoring, HLA-B27 testing, rheumatoid factor/anticyclic citrullinated peptide testing, and Lyme serology testing. Two additional items (numerous or repeated intraarticular corticosteroid injections, and autoinflammatory diseases genetic testing) were also selected. Literature review was performed for these 7 highest priority items.